Schick delays release of quarterly results

Article

Digital radiography developer Schick Technologies continues to experience problems meeting reporting requirements of the Securities and Exchange Commission. The Long Island, NY-based company has filed a Notification of Late Filing for its first quarter

Digital radiography developer Schick Technologies continues to experience problems meeting reporting requirements of the Securities and Exchange Commission. The Long Island, NY-based company has filed a Notification of Late Filing for its first quarter (end-June 30), indicating that it has not filed a Form 10-Q and that it does not expect to file it within the five-day extension period permitted by the notice of late filing. The latest reporting delay comes on the heels of the company’s failure to file a Form 10-K for fiscal year 1999 (end-March 31) (SCAN 7/7/99), following the discovery of potential errors in the recognition and recording of certain sales transactions. The company has initiated an independent investigation of its revenue recognition and sales practices, which has further delayed the filing of its annual report, according to Schick.

Schick expects to report a decrease in revenues and an increase in net loss for the quarter compared to revenues of $12.4 million and a net loss of $324,000 for the same period a year ago. A day after announcing its late filing, Schick released news of the resignations of vice president of sales and marketing Fred Levine and vice president of operations Avi Itzhakov.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.